ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683516; 2) Community: the network communities that were significantly associated with the response to NSC 683516; 3) Molecule: the relationships between components within communities and NSC 683516; 4) MDR: the compounds that were significantly associated with the NSC 683516.

NSC Compound Enrichment Correlation
NSC 732822 N1-(3-trifluoromethylphenyl)-3-(1-benzyl-4-chloro-2,5-dioxo- 2,5-dihydro-1H-3-pyrrolylamino)benzamide 0.0312262198176281 0.40629283
NSC 744650 Null 0.0312262198176281 0.39687336
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0312262198176281 0.33860019
NSC 749117 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline 0.0312262198176281 0.13711154
NSC 764037 BP-1-102 0.0312262198176281 0.28326171
NSC 10466 Aizen Magenta 0.0312262198176283 0.41990336
NSC 116878 Cardiac glycoside 0.0312262198176283 -0.055598967
NSC 13317 Null 0.0312262198176283 0.13867517
NSC 145168 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- 0.0312262198176283 0.16698612
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0312262198176283 0.49778412
Total:79  Current:53    [First] [Prev] [Next] [Last]